Guanylhydrazones with potential antileukemic activity. 1. Aza analogs of 4,4'-diacetyldiphenylurea bis(guanylhydrazone).
D000230:Adenocarcinoma / Q000188:drug therapy; D000818:Animals; D000970:Antineoplastic Agents / Q000138:chemical synthesis* / Q000627:therapeutic use; D001372:Aza Compounds / Q000138:chemical synthesis / Q000627:therapeutic use; D004254:DNA Nucleotidyltransferases / Q000378:metabolism; D004273:DNA, Neoplasm / Q000096:biosynthesis; D006147:Guanine / Q000138:chemical synthesis / Q000627:therapeutic use; D006835:Hydrazones / Q000138:chemical synthesis / Q000627:therapeutic use; D007939:Leukemia L1210 / Q000188:drug therapy / Q000201:enzymology / Q000378:metabolism; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy; D051379:Mice; D008811:Mice, Inbred DBA; D013329:Structure-Activity Relationship; D014508:Urea / Q000138:chemical synthesis* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D001372:Aza Compounds; D004273:DNA, Neoplasm; D006835:Hydrazones; D006147:Guanine; D014508:Urea; D004254:DNA Nucleotidyltransferases